|
Cellular Schwannoma |
Malignant Peripheral Nerve Sheath Tumor |
Age |
Wide age range, peak in third to sixth decades |
Wide age range, peak in third to sixth decades |
Location |
Virtually any location, most common in extremities or head and neck |
Virtually any location, most common in extremities and trunk. Uncommon in the head and neck |
Symptoms |
Slow-growing mass, usually painless |
Slow-growing mass, sometimes painful |
Signs |
Variably sized masses usually arising in association with a major nerve |
Large, deep-seated mass, usually arising in association with a major nerve |
Etiology |
A subset of tumors are associated with familial tumor syndromes (schwannomatosis, neurofibromatosis type 2) |
A subset occur in the setting of neurofibromatosis type 1. Some arise in preexisting neurofibromas (but almost never in schwannomas) |
Histology |
Well-circumscribed, encapsulated proliferation of spindled cells arranged in short fascicles or whorls
Predominated by cellular (“Antoni A”) areas admixed with few or no less cellular, myxoid (“Antoni B”) zones (Fig. 4.3.1)
Tumor nuclei elongated, wavy, with tapered ends (Fig. 4.3.2)
Verocay bodies (palisaded arrangement of tumor nuclei) may be present
A lymphoid cuff and hyalinized vessels are also commonly seen (Fig. 4.3.2)
May be mitotically active but not in proportion with degree of cellularity. No atypical mitoses or necrosis
Some examples demonstrate “ancient changes” in the form of degenerative nuclear atypia, cystic change, hyalinization, hemorrhage, and calcification (Fig. 4.3.3)
No heterologous differentiation
|
Unencapsulated, infiltrative proliferation of spindled cells, typically arranged in a swirling and/or herringbone-type fascicular pattern (Fig. 4.3.5)
Often “dark” hypercellular areas alternate with “light,” less cellular ones, leading to a so-called marbleized appearance (Fig. 4.3.5)
Tumor nuclei elongated, wavy, with tapered ends (Fig. 4.3.6)
No Verocay bodies, lymphoid cuff, or hyalinized vessels
Highly cellular and exhibits nuclear hyperchromasia, pleomorphism, elevated mitotic rates, and necrosis (Fig. 4.3.6)
Up to 10%-15% contain heterologous elements, the most frequent of which are foci of rhabdomyoblastic (so-called malignant triton tumor) or epithelial differentiation (Fig. 4.3.7)
|
Special studies |
Diffusely positive for S100 and SOX10 (Fig. 4.3.4) |
Focal or negative for S100 and SOX10 (Fig. 4.3.8) |
Treatment |
Surgical excision |
Wide resection, radiation, with or without chemotherapy |
Prognosis |
Excellent. Recurrences are rare. Schwannomas almost never give rise to malignant peripheral nerve sheath tumors |
Poor. Five-year survival 30%-60% |